Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,835,226
+$1,875,617 QoQ
Shares Held
4,865
+13.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#1,592
of 4,605 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NatWest Group plc holds $63,512,390 across 5 Drug Manufacturers - General names. LLY ranks #4 (9.2% of the industry book) .
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,835,226 | 4,865 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $3,959,609 | 4,305 | Shares | Defined | 2026-05-11 | |
| 2025-03-31 | $233,732 | 283 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $218,476 | 283 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $12,611,355 | 14,235 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $12,548,566 | 13,860 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $10,762,298 | 13,834 | Shares | Defined | 2024-04-19 | |
| 2023-12-31 | $8,746,714 | 15,005 | Shares | Defined | 2024-01-12 | |
| 2023-09-30 | $9,312,759 | 17,338 | Shares | Defined | 2023-10-12 | |
| 2023-06-30 | $7,824,930 | 16,685 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $5,663,682 | 16,492 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $5,917,461 | 16,175 | Shares | Defined | 2023-01-27 | |
| 2022-09-30 | $5,210,461 | 16,114 | Shares | Defined | 2022-10-31 | |
| 2020-12-31 | $507,025 | 3,003 | Shares | Defined | 2021-02-04 | |
| 2020-09-30 | $878,646 | 5,936 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $974,572 | 5,936 | Shares | Defined | 2020-07-16 | |
| 2020-03-31 | $925,539 | 6,672 | Shares | Defined | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||